The Latest Breaking News from IDXX

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 6.71% on an annualized basis producing an average annual return of 13.47%. Currently, IDEXX Laboratories has a market capitalization of $28.24 billion.

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 5 years by 6.05% on an annualized basis producing an average annual return of 16.93%. Currently, IDEXX Laboratories has a market capitalization of $31.37 billion.

Skyrocketing inflation, the possibility of aggressive interest rate hikes, and increasing sanctions on Russia have been causing immense volatility in the stock market. Amid such uncertain market conditions, it could be wise to bet on high-quality stocks Cadence Design (CDNS), PTC (PTC), IDEXX Laboratories (IDXX), Mettler-Toledo (MTD), and Manhattan Associates…

Given the unprecedented increase in pet ownership since the onset of the COVID-19 pandemic, rising consumer spending on pet food, medications, and other ancillary pet services has driven the pet care industry’s growth. Because high demand is expected to persist going forward, prominent pet stocks IDEXX Laboratories (IDXX) and Elanco…

Pet ownership has skyrocketed during the COVID-19 pandemic, driving the demand for medications, pet food, and other pet-related services. So, beaten-down pet stocks Zoetis (ZTS) and IDEXX Laboratories (IDXX) could bounce back in the near term because the demand for pet-related products and services is expected to grow. So, let’s…

IDEXX Laboratories Inc (NASDAQ: IDXX) reported 

A growing demand for early medical diagnosis is driving the market for advanced medical equipment by healthcare centers and hospitals. Also, increasing spending on research & development by medical technology companies to deliver innovative technology is helping the industry rebound. So, we think the recent price dips in the stocks…